Observational Study Evaluating Safety in Patients With Type 2 Diabetes Treated With NovoMix 30 or NovoMix 50 or NovoMix70 (Biphasic Insulin Aspart).
Phase of Trial: Phase IV
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms Mix2Mix
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 20 Nov 2009 Actual patient number (546) added as reported by ClinicalTrials.gov.
- 20 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.